Individualized Therapy For Asthma in Toddlers

• Status: Completed
• Trial end date: 2015-04-01

Summary

The INFANT study will test whether, in preschool children 12-59 months of age with persistent asthma, the following Step 2 asthma therapies will provide similar degrees of asthma control:

1. Daily inhaled corticosteroid (ICS) treatment,

2. Daily leukotriene receptor antagonist (LTRA) treatment, and

3. As-needed ICS plus short-acting beta agonist (as-needed ICS/SABA) rescue treatment.

• Phase: Phase 3

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Fluticasone; Montelukast; Xhance